CD274 and cancer: The researchers found that after administration of AMD3100 for inhibition of chemokine (C-X-C motif) ligand 12 (CXCL12) receptor 4, T cells were rapidly recruited in cancer cells and acted synergistically with α-PD-L1 to dramatically reduce cancer cell proliferation and metastasis.